Assessing Clinical Impressions of Early Warning Score Integration With the Rapid Response Team: Protocol for a Prospective Cohort Study.
Alexandre Tran, Rashi Ramchandani, Jamie Brehaut...
https://pubmed.ncbi.nlm.nih.gov/40742731Actively Recruiting
Led by Ottawa Hospital Research Institute · Updated on 2025-05-14
140
Participants Needed
1
Research Sites
N/A
Total Duration
Rapid response teams (RRTs) are used in hospitals to provide urgent care to patients who need quick attention to prevent worsening health. Early warning scores (EWS) help identify which patients need RRT assessment by analyzing vital signs and lab results. The Visensia Safety Index (VSI) is an EWS that uses continuous vital sign monitoring and machine learning to predict patient deterioration and can connect with hospital data systems. Previous studies showed VSI could reduce instability duration and serious episodes. This study aims to test the feasibility and impact of using VSI with a portable monitoring system at The Ottawa Hospital to identify high-risk patients earlier. Patients in this study will have their vital signs continuously monitored by the VSI, which alerts the Rapid Assessment of Critical Events (RACE) team if deterioration is detected. The VSI device will be integrated into patient care to provide real-time alerts to hospital staff. This is a single-arm study evaluating the implementation and use of the VSI monitoring system alongside the RACE team for early detection of patient decline. Participants will be observed over a 10-month period to assess the technical feasibility of capturing and transmitting continuous data to the VSI tool, and the clinical feasibility based on feedback from doctors, nurses, and respiratory therapists. The study will also evaluate the financial feasibility of using VSI. Key outcomes include the rate of data collection, alert reporting to RACE, and opinions of healthcare providers. The potential clinical and financial impacts of VSI will be assessed upon study completion.
CONDITIONS
Feasibility and Initial Clinical Impressions of Predictive Monitoring Integrated With the RACE Team
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 10 months
Participants undergo continuous vital sign monitoring using the Visensia Safety Index (VSI) to identify early deterioration and notify the RACE team.
Continuous monitoring throughout hospitalization
Total: 1 location
1
The Ottawa Hospital
Ottawa, Ontario, Canada, K1H 8L6
Actively Recruiting
A
Andrew JE Seely, MD, PhD, FRCSC
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Alexandre Tran, Rashi Ramchandani, Jamie Brehaut...
https://pubmed.ncbi.nlm.nih.gov/40742731